改善线粒体功能障碍,用于治疗帕金森病
Qing Zheng1, Hanghang Liu1,2, Yifan Gao1
1Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Suzhou Medical College, Soochow University, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou, 215123, China.
Small (Weinheim an der Bergstrasse, Germany)
|February 22, 2024
概括
线粒体功能障碍是帕金森病 (PD) 进展的关键因素. 准线粒体为治疗这种无法治愈的神经退行性疾病提供了一个有希望的治疗策略.
科学领域:
- 神经退行性疾病的神经退行性疾病
- 细胞生物学 细胞生物学
- 线粒体医学是指线粒体医学.
背景情况:
- 帕金森病 (PD) 是一种主要的不可治愈的神经退行性疾病.
- 线粒体是细胞的能量生产者,对神经元功能至关重要.
- 线粒体功能障碍与PD的发病和进展有关.
研究的目的:
- 审查线粒体功能障碍和PD之间的复杂关系.
- 探索PD中线粒体功能障碍的原因和后果.
- 概述PD目前和新兴的线粒体向治疗策略.
主要方法:
- 系统的文献审查.
- 分析线粒体在PD中的作用.
- 针对线粒体功能障碍的治疗干预措施的评估.
主要成果:
- 线粒体功能障碍显著促进了PD的发展和进展.
- 旨在改善线粒体功能障碍的策略显示了PD的治疗潜力.
- 针对线粒体的疗法是PD治疗的快速发展领域.
结论:
- 解决线粒体功能障碍对于有效的PD治疗至关重要.
- 对线粒体向治疗的进一步研究对于克服PD挑战至关重要.
- 了解线粒体的作用为PD中神经保护提供了新的途径.
相关概念视频
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Mitochondria
12.6K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.6K


